Results 301 to 310 of about 400,342 (335)
A cervical spine metastasis of a hepatocellular carcinoma: a rare presentation. [PDF]
Future Sci OAMerhaben S +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Mechanisms of drug resistance in HCC
Hepatology, 2023HCC comprises ∼80% of primary liver cancer. HCC is the only major cancer for which death rates have not improved over the last 10 years. Most patients are diagnosed with advanced disease when surgical and locoregional treatments are not feasible or ...
Alexandra D. Ladd +3 more
semanticscholar +1 more source
Hepatology, 2021
Recently, clinical trials of lenvatinib plus pembrolizumab in HCC have displayed an impressive objective response rate. This study aimed to clarify the mechanism for optimal patient selection.
Chenhe Yi +12 more
semanticscholar +1 more source
Recently, clinical trials of lenvatinib plus pembrolizumab in HCC have displayed an impressive objective response rate. This study aimed to clarify the mechanism for optimal patient selection.
Chenhe Yi +12 more
semanticscholar +1 more source
Journal of Hepatology, 2012
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the management of which has significantly improved during the last few years. A better knowledge of the natural history of the tumor and the development of staging systems that stratify patients according to the characteristics of the tumor, the liver disease, and the ...
Alejandro Forner +4 more
openaire +2 more sources
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the management of which has significantly improved during the last few years. A better knowledge of the natural history of the tumor and the development of staging systems that stratify patients according to the characteristics of the tumor, the liver disease, and the ...
Alejandro Forner +4 more
openaire +2 more sources
Reviews on Recent Clinical Trials, 2008
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with increasing incidence in the Western World. In contrast to most other malignancies, only surgical and local ablative therapeutic options have shown efficacy in patients with HCC. Systemic chemotherapy has failed to show a substantial benefit for these patients.
Tim F. Greten +2 more
openaire +3 more sources
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with increasing incidence in the Western World. In contrast to most other malignancies, only surgical and local ablative therapeutic options have shown efficacy in patients with HCC. Systemic chemotherapy has failed to show a substantial benefit for these patients.
Tim F. Greten +2 more
openaire +3 more sources
Abdominal Imaging, 2011
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Ángeles García-Criado +2 more
openaire +2 more sources
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Ángeles García-Criado +2 more
openaire +2 more sources
Biochemical Genetics, 2023
Racial/ethnic and region disparities in incidence and mortality are obviously in liver cancer. Mongolia has the highest reported incidence and mortality of hepatocellular carcinoma (HCC) in the world, while the incidence of HCC is relatively low in the United States, but differences in their molecular characteristics remain largely elusive.
Rui, Huang +6 more
openaire +2 more sources
Racial/ethnic and region disparities in incidence and mortality are obviously in liver cancer. Mongolia has the highest reported incidence and mortality of hepatocellular carcinoma (HCC) in the world, while the incidence of HCC is relatively low in the United States, but differences in their molecular characteristics remain largely elusive.
Rui, Huang +6 more
openaire +2 more sources
Clinics in Liver Disease, 2009
Primary liver cancer is the fifth most common malignancy worldwide and the third leading cause of cancer mortality. Non-alcoholic fatty liver disease is the most common cause of chronic liver disease in the United States encompassing a spectrum of entities marked by hepatic steatosis in the absence of significant alcohol consumption.
Stephen A. Harrison, John M. Page
openaire +3 more sources
Primary liver cancer is the fifth most common malignancy worldwide and the third leading cause of cancer mortality. Non-alcoholic fatty liver disease is the most common cause of chronic liver disease in the United States encompassing a spectrum of entities marked by hepatic steatosis in the absence of significant alcohol consumption.
Stephen A. Harrison, John M. Page
openaire +3 more sources